ドラッグデリバリーデバイスの世界市場：投与経路別、用途別、エンドユーザー別、地域別

世界のドラッグデリバリーデバイスの市場規模は、2024年に2,102億米ドルに達し、2024～2031年にかけてCAGR 8.8％で成長し、2031年には3,791億1,000万米ドルに達すると予測されています。

図.ドラッグデリバリーデバイス市場シェア（%）、2024年、地域別

ドラッグデリバリーデバイスとは、医薬化合物を体内で輸送するために使用される様々な技術を指します。ドラッグデリバリーを効果的に行うことで、作用部位で適切な濃度の医薬品有効成分を確実に利用できるようになります。薬剤の有効性と患者のコンプライアンスを向上させるのに役立ちます。生物製剤の急速な発展、個別化医療、慢性疾患の増加により、高度なドラッグデリバリーシステムの需要が高まる可能性があります。安全性、正確性、使いやすさの向上に焦点を当てたドラッグデリバリーデバイスの絶え間ない技術革新が、近い将来の市場成長を促進する可能性があります。

市場力学：

世界のドラッグデリバリーデバイス市場の成長は、糖尿病、がん、心血管疾患などの慢性疾患の罹患率の上昇が牽引しています。老人人口の増加とヘルスケア支出の増加も市場成長の原動力となっています。しかし、高度な送達システムの開発に伴う高コストが市場成長の妨げとなる可能性があります。また、革新的な製品に対する規制上のハードルも市場成長の妨げとなる可能性があります。新興国は市場参入者にとって有利な機会を提供します。自己投与注射器や在宅医療に対する需要の高まりは、市場成長の機会となり得る。携帯型・装着型送達システムの継続的な技術進歩も成長機会を提供します。モノのインターネットに対応したスマートデバイスの採用は、市場の主要動向です。

本調査の主な特徴

本レポートでは、世界のドラッグデリバリーデバイス市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界のドラッグデリバリーデバイス市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主要企業には、Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, Nemeraなどが含まれます。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

ドラッグデリバリーデバイスの世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。

利害関係者は、世界のドラッグデリバリーデバイス市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーターの分析
• 合併と買収のシナリオ

第4章 世界のドラッグデリバリーデバイス市場、投与経路別、2019～2031年（10億米ドル）

• 経口
• 非経口
• 経皮
• 眼

第5章 世界のドラッグデリバリーデバイス市場、用途別、2019～2031年（10億米ドル）

• 腫瘍学
• 感染症
• 呼吸器疾患
• 糖尿病
• 心血管疾患
• 自己免疫疾患
• 中枢神経系疾患

第6章 世界のドラッグデリバリーデバイス市場、エンドユーザー別、2019～2031年（10億米ドル）

• 病院
• 診断センター
• 外来手術センター/クリニック
• ホームケア設定
• その他

第7章 世界のドラッグデリバリーデバイス市場、地域別、2019～2031年（10億米ドル）

• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東

第8章 競合情勢

• Abbott Laboratories
• Adherium Ltd.
• Amiko Digital Health Limited
• Becton, Dickinson and Company
• BIOCORP
• CeQur Corporation
• Cognita Labs
• E3D Elcam Drug Delivery Devices
• H&T Presspart Manufacturing Ltd.
• HCmed Innovations Co., Ltd.
• Medtronic plc
• Novo Nordisk A/S
• Phillips-Medisize
• Sonceboz
• Enable Injections, Inc.
• NOVO Engineering
• Elcam Medical
• Battelle
• Gerresheimer AG
• Aphios

第9章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社

Global drug delivery device market is estimated to be valued at USD 210.20 Bn in 2024 and is expected to reach USD 379.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Figure. Drug Delivery Device Market Share (%), By Region 2024

Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.

Market Dynamics:

Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.

Key features of the study:

This report provides in-depth analysis of the global drug delivery device market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market

Detailed Segmentation-

• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Oral
  • Parenteral
  • Transdermal
  • Ocular
  • Pulmonary
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others
• By Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Adherium Ltd.
  • Amiko Digital Health Limited
  • Becton, Dickinson and Company
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Delivery Device Market, By Route of Administration
  • Global Drug Delivery Device Market, By Application
  • Global Drug Delivery Device Market, By End User
  • Global Drug Delivery Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Drug Delivery Device Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ocular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pulmonary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Delivery Device Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Central Nervous System Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Delivery Device Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgery Centers/Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Delivery Device Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Adherium Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amiko Digital Health Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BIOCORP
• CeQur Corporation
• Cognita Labs
• E3D Elcam Drug Delivery Devices
• H&T Presspart Manufacturing Ltd.
• HCmed Innovations Co., Ltd.
• Medtronic plc
• Novo Nordisk A/S
• Phillips-Medisize
• Sonceboz
• Enable Injections, Inc.
• NOVO Engineering
• Elcam Medical
• Battelle
• Gerresheimer AG
• Aphios

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us